Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: TENX) Delayed: 1.97 +0.11 (5.91%)
Previous Close $1.86    52 Week High $3.40 
Open $1.92    52 Week Low $1.34 
Day High $1.97    P/E N/A 
Day Low $1.85    EPS $0.00 
Volume 2,948,221